In addition to nectin-3, recently identified as potential mediators in stress-related disorders25, our study highlights MMP-9 activity as a novel target for the treatment of stress-related neuropsychiatric disorders, in particular depression, which is typically characterized by deficits in the social and cognitive domains. Here, NECTIN3 is linked to depressive symptom measurement.